Swing Trade Ideas

🏃🚀 CAST HIGH 2.07, UP 60%

✅ QTEX entry: .75

🎯 PT1: 1.00–1.50 🎯 PT2: 1.60–2.00 🎯 PT3: 2.10–2.80

🚫 Stop: Below .700 or 2%–5%, or your maximum daily risk per trade.

🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup

 Company focuses in quantum infrastructure, cryogenic interconnect systems, and advanced electronics manufacturing for quantum computing applications, recently awarded $1M grant by Israel Innovation authority for Quantum RF Dielectric development, also recently received purchase order from Fortune 500 customer for AME system, related material from unnamed UAE Firm, received $580,000 NYU Langone order for FDA-cleared ART100, recently launched research collaboration with Northeastern University on cryogenic quantum interconnects, does have mixed shelf 

 ✅ CAST Entry: 1.20
🎯 PT1: 1.50-1.80
🎯 PT2: 1.90-2.50
🎯 PT3: 2.60-3.40
🚫 Stop: Below 1 or 2%-5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

 recently launched Beyond Media industry research series on streaming-telecom convergence, also recently partnered with Brazil's RBTI to add 28 TV channels,  streaming technology company that develops software platforms helping consumers and businesses aggregate streaming TV services into a single interface,  recently signed Starlink Business reseller agreement to offer satellite broadband services,  announced FreeCast Cities, a free local streaming platform designed for all 210 U.S television markets, also recently signed WIRE3 to deliver white-label streaming platform for fiber subscribers, partnered with FPUnet to offer streaming platform services to 30,000 Fort Pience-area homes 

 🎯 PT1: 4–4.50 | 🎯 PT2: 4.60–5 | 🎯 PT3: 5.05–5.80
🚫 Stop: Below 3.50 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

 back from recent high above 18, offshore digital marketing company, recently 1/16 reverse split 

 ✅ MSS Entry: $1.45–1.50
🎯 PT1: $1.70–2.20
🎯 PT2: $2.30–2.50
🎯 PT3: $2.60–2.80
🚫 Stop: Below $1.25 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

 back to support from recent high, company is a specialty grocery retailer, recently received 2026 global recognition award in Innovation category 

✅ OLOX Entry: $1.40–$1.50

🎯 PT1: $1.70–$2.30
🎯 PT2: $2.40–$2.80
🎯 PT3: $2.90–$3.60

🚫 Stop: Below $1.30 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup

 company is building a vertically integrated energy, digital infrastructure, and $BTC.X / AI compute , its operations now include oil/gas assets, energy services, industrial loT technology through Machfu, modular infrastracture, recently signed LOI to acquire Wildboy Holdings and IPD industries for about $20 Mln 

 ✅ FRTT entry: $1
🎯 PT1: $1.30–$1.80
🎯 PT2: $1.85–$2.50
🎯 PT3: $2.60–$4
🚫 Stop: Below $0.80 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

 back to key support, recently announced to acquire 50.1% Stake in data center fuel integrity provider Logia USA, expected to close 10/1/2026, ISP Global Capital purchased 144,000 shares of FRTT, set price target to $10 

 ✅ EZGO Entry: $1.00
🎯 PT1: $1.30–$1.80
🎯 PT2: $1.90–$2.50
🎯 PT3: $2.60–$2.90
🚫 Stop: Below $0.80 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast-Moving | Technical Setup 

  ✅ HUBC potential entry: $.70
🎯 Potential PT1: $1.00-$1.60 🎯 PT2: $1.70-$2.50 🎯 PT3: $2.60-$3.50
⛔ Potential Stop: Below $.65 or 2%-5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

 recently regained compliance, AI , cybersecurity focused on confidential computing, cyber-secured infrastructure, data fabric, and protecting sensitive government and enterprise data, 

 ✅ PRSO Entry: .60
🎯 PT1: .80 - 1.70
🎯 PT2: 1.80 - 2.50
🎯 PT3: 2.60 - 3.20
🚫 Stop: Below .55 or 2%-5% or daily max risk per trade
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup 

 recently announced delivery shipment of 60GHz modules for drone IFF systems, previously announced collaboration with Virewirx, previously secured $1.1M through inducement offer agreement, ,secured $0.9M order from FWA equipment supplier, partnered with WeLink to expand access to high-speed broadband across dense US metro areas, company focuses on fabless semiconductor/mmWave wireless technology, , Benchmark Co buy rating, price target $3, Ladenburg Thalmann price target $3.25 

 ✅ SUNE entry: 2.1–2.2
🎯 PT1: 2.5–2.8 | PT2: 2.9–3.4 | PT3: 3.5–3.9
⛔ Stop: Below 2 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

 back to near support, solar energy company focused on helping homeowners, businesses and municipalities reduce electricity costs through solar power and energy storage 

 ✅ ATPC entry: $2.40–$2.45
🎯 PT1: $2.70–$3.80 | PT2: $3.85–$4.50 | PT3: $4.60–$5.00
🛑 Stop: Below $2.00, or 2%–5%, or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast-Moving | Technical Setup 

 back to support from recent high, Company focuses on health and wellness products, renewable energy and sustainability initiatives, previously entered collaboration with Citadel Investment for opportunities in Oil, gas, and petroleum products 

 ✅ AIIO Entry: 2.8
🎯 PT1: 3 - 3.8 | PT2: 3.9 - 4.5 | PT3: 4.6 - 5.6
⛔ Stop: Below 2.6 or 2%-5% or daily max risk per trade
🔴 Risk Level: High | Fast-Moving | Technical Setup 

 its subsidiary Neurovia AI joins UAE Government cybersecurity summit as offcial AI cybersecurity partner, company is a Dubai-based AI and robotics company focused on AI-powered robotics platforms, AI operating systems, does have mixed shelf, be mindful on next spike 

  ✅ BMEA Entry: 1.20
🎯 PT1: 1.50–1.80 | PT2: 1.90–2.60 | PT3: 2.70–3.50
🛑 Stop: Below 1 or 2%–5% or daily max risk per trade
🟡 Risk Level: Medium | Catalyst-Driven | Technical Setup 

back to support from recent high, company focuses on oral small molecule therapies for metabolic disease, such as type to diabetes and obesity, lead candidate icovamenib, targets a key protein involved in gene regulation, aiming to improve glycemic control and metabolic outcomes, upcoming catalyst: 1) Q1 2026 to enroll first participant in COVALENT -211 phase IIb trial and provide business update, Director and Officer Rainer Erdtmann recently acquired shares, Interim CEO & director recently bought 667% more shares, Rodman & Renshaw buy rating, D. Boral Capital price target $12.00, HC Wainwright buy rating, Citigroup price target $7

  ✅ QTEX entry: .95
🎯 PT1: 1.10 - 1.50 | PT2: 1.60 - 2 | PT3: 2.10 - 2.80
⛔ Stop: Below .80 or 2%-5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

back to support from recent high, Company focuses in quantum infrastructure, cryogenic interconnect systems, and advanced electronics manufacturing for quantum computing applications, recently awarded $1M grant by Israel Innovation authority for Quantum RF Dielectric development, also recently received purchase order from Fortune 500 customer for AME system, related material from unnamed UAE Firm, received $580,000 NYU Langone order for FDA-cleared ART100,

 ✅ EZGO Entry: 1.1
🎯 PT1: 1.3–1.8 | 🎯 PT2: 1.9–2.5 | 🎯 PT3: 2.6–2.9
🚫 Stop: Below 1 or 2%–5%, or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

 back to support from recent high, company focused on electric bicycles and scooters, battery and charging technologies, battery recycling and related services, recently received Changzhou regulatory approval to begin operations at completed factory in Jiangsu Province to scale electric scooter, battery output 

 CAST

✅ Entry: 1.20–1.30
🎯 PT1: 1.50–1.80 | 🎯 PT2: 1.9–2.5 | 🎯 PT3: 2.6–3.4
🚫 Stop: Below 1 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup

 back to support from recent high above $12, streaming technology company that develops software platforms helping consumers and businesses aggregate streaming TV services into a single interface,  recently engaged ex-Pentagon, Space Force Telecoms veteran Gillot as strategic consultant, recently announced targeting the multi-billion dollar U.SA local advertising market with a unified platform across 210 television markets,  recently signed Starlink Business reseller agreement to offer satellite broadband services,  announced FreeCast Cities, a free local streaming platform designed for all 210 U.S television markets, also recently signed WIRE3 to deliver white-label streaming platform for fiber subscribers, partnered with FPUnet to offer streaming platform services to 30,000 Fort Pience-area homes, does have mixed shelf 

 ✅ GMEX Entry: 1.20
🎯 PT1: 1.60–1.90 🎯 PT2: 2–2.60 🎯 PT3: 2.70–3.80
🚫 Stop: Below 1, 2%–5%, or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

recent reverse split, ultra small float, recently received first deployment order under agreement with Australian Hospitality food and Beverage Group, received first deployment order for Bon Vivant 3.0 cooking robot machines, company develops autonomous robotic systems for hospital logistics and healthcare automation, food-service and kitchen robotics, industrial and commercial robotics applications

  ✅ EZRA entry: 2.50
🎯 PT1: 2.70–3.20 | 🎯 PT2: 3.30–3.80 | 🎯 PT3: 3.90–4.70
🚫 Stop: Below 2.20, 2%–5%, or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

 a tech-driven insurance holding company, ultra small float, 

 ✅ CUPR potential entry: $3.20–3.25
🎯 PT1: $3.50–4.00 🎯 PT2: $4.10–4.70 🎯 PT3: $4.80–5.70
🚫 Potential Stop: Below $3.00 or 2%–5%, or your maximum daily risk per trade.
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

 back to support from recent high above 14, company focused on advanced chronic wound care products, infertility, medical waste recycling and cosmeceutical products, recently won landmark fda 510k clearance for Medifly maggots wood debridement product, does have mixed shelf 

 ✅ $VANI potential entry: $1.30–1.35

🎯 PT1: $1.50–1.90 🎯 PT2: $2.00–2.50 🎯 PT3: $2.60–3.80

🚫 Potential Stop: Below $1.00 or 2%–5%, or your maximum daily risk per trade.

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 company developing miniature, ultra-long-acting drug implants, lead programs focus on GLP-1 therapies for obesity and diabetes, using implant technology, recently signed deal with  $NVO Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management, recently entered merger deal with ClearOne $CRGT , Analyst buy rating, price target $3.50, Lake Street buy rating price target $4, Maxim Group buy rating, Director Gregg Williams recently purchased shares worth $2 million 

✅ HUBC Entry: .9

🎯 PT1: 1.30–1.80 🎯 PT2: 1.90–2.50 🎯 PT3: 2.60–3.50

🚫 Stop: Below .85 or 2%–5%, or your maximum daily risk per trade.

🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup

 recently regained compliance,  AI , cybersecurity focused on confidential computing, cyber-secured infrastructure, data fabric, and protecting sensitive government and enterprise data, avoid holding for the moon, goal is green, not greed, high risk for potential future reverse split 

 ONCY entry: 0.70

🎯 PT1: 1.00–1.60🎯 PT2: 1.70–2.50 🎯 PT3: 2.60–3.80

🚫 Potential Stop: Below 0.70 or 2%–5%, or your maximum daily risk per trade.

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 development of first in class intravenously delivered oncolytic virus designed to selectively destroy cancer cells and stimulate the immune system against tumors, previously announced promising Pelareorep data in colorectal cancer, FDA recently agreed on phase 3 trial design for elareorep in pancreatic cancer, planning to launch immunotherapy trial in pancreatic cancer in 2026, Lake Street buy rating, RBC Capital buy rating, HC Wainwright raised target price to $10 from $5, director James T. Parsons recently acquired shares 

  ✅ CRDL entry: 1.15–1.20
🎯 PT1: 1.40–1.80 🎯 PT2: 1.90–2.60 🎯 PT3: 2.70–3.50
🚫 Stop: Below 1.00 or 2%–5%, or your maximum daily risk per trade.
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup 

 recently announced positive phase II ARCHER Trial data for CardioIRx, recently secured USA patent for hear drugs, company focuses on novel anti-inflammatory and anti-fibrotic therapies for heart disease, its lead drug, CardioIRx (an oral cannabidiol formulation) is designed to treat serious cardiac conditions like acute myocarditis and recurrent pericarditis by modulating inflammatory pathways involved in fibrosis and heart damage.  First Berlin Equity Research price target $7.50, Canaccord Genuity buy rating, HC Wainwright price target $9, does have mixed shelf 

 ✅ RKTO entry: .75–.80
🎯 PT1: 1.10–1.60 🎯 PT2: 1.70–2.40 🎯 PT3: 2.50–2.90
🚫 Stop: Below .70 or 2%–5%, or your maximum daily risk per trade.
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

 former $HOTH , company pivoted to AI semiconductor technology, radiation-tolerant computing, space infrastructure, defense applications, recently announced retired NASDA astronaut Col. Robert "Shane" Kimbrough to its Space Advisory Board, Kimbrough was involved with Expedition 50 aboard the International Space Station and $SPCX crew-2 mission